Insight into the genetics of hypertension, a core component of the metabolic syndrome

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 4, 2008, Pages 393-397

  Pravenec, Michal ^a   Petretto, Enrico ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Animal models; Genetics; Genome wide association studies; Hypertension

Indexed keywords

BIOLOGICAL MARKER; DNA;

CLINICAL GENETICS; ESSENTIAL HYPERTENSION; GENE EXPRESSION PROFILING; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; HUMAN GENOME; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BIOLOGICAL MODEL; GENETIC RECOMBINATION; GENETICS; GENOME; HYPERTENSION; TRANSGENIC ANIMAL;

ANIMALIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENOME, HUMAN; HUMANS; HYPERTENSION; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; METABOLIC SYNDROME X; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINATION, GENETIC;

EID: 54049084595     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32830366f6     Document Type: Review

References (45)

1. Flatman PW. Cotransporters, WNKs and hypertension: important leads from the study of monogenetic disorders of blood pressure regulation. Clin Sci (Lond) 2007; 112:203-216.
2. Rosskopf D, Schurks M, Rimmbach C, Schafers R. Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol 2007; 374:429-469.
3. Weder AB. Genetics and hypertension. J Clin Hypertens (Greenwich) 2007; 9:217-223.
4. Ragland DR. Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology 1992; 3:434-440.
5. Corbett J, Gu CC, Rice J, et al. Power loss for linkage analysis due to the dichotomization of trichotomous phenotypes. Hum Hered 2004; 57:21-27.
6. Arnett DK, Baird AE, Barkley RA, et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007; 115:2878-2901.
7. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6:95-108.
8. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:151 6-1517.
9. Lin BK, Clyne M, Walsh M, et al. Tracking the epidemiology of human genes in the literature: the HuGE published literature database. Am J Epidemiol 2006; 164:1-4.
10. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med 2002; 4:45-61.
11. Ioannidis JPA. Why most published research findings are false positive. PLoS Med 2005; 2:e124.
12. Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false: but a little replication goes a long way. PLoS Med 2007; 4:e28.
13. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-872.
14. Kavvoura FK, Liberopoulos G, Ioannidis JP. Selection in reported epidemiological risks: an empirical assessment. PLoS Med 2007; 4:e79.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, Ser B 1995; 57:289-300.
16. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst 2004; 96:421-423.
17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447:661-678.
18. Ott J. Association of genetic loci. Replication or not, that is the question. Neurology 2004; 63:955-958.
19. Levy D, Larson MG, Benjamin EJ, et al. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007; 8 (Suppl 1):S3.
20. Laird NM, Horvath S, Xu X, et al. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1):S36-S42.
21. Iyengar SK, Elston RC. The genetic basis of complex traits: rare variants or common gene, common disease'? Methods Mol Biol 2007; 376:71-84.
22. Wright A, Charlesworth B, Rudan I, et al. A polygenic basis for late-onset disease. Trends Genet 2003; 19:97-106.
23. Ji W, Foo JN,O' Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592-599.
24. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet 2007; 39 (7 Suppl):S37-S42.
25. Conrad B, Antonarakis SE. Gene duplication: a drive for phenotypic diversity and cause of human disease. Annu Rev Genomics Hum Genet 2007; 8:17-35.
26. Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851-855.
27. Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39:721-723.
28. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315:848-853.
29. Weedon MN. The importance of TCF7L2. Diabet Med 2007; 24:1062-1066.
30. Cicila GT, Rapp JP, Wang JM, et al. Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet 1993; 3:346-353.
31. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002; 298:2345-2349.
32. Aitman TJ, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21:76-83.
33. Pravenec M, Landa V, Zidek V, et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001; 27:156-158.
34. Pravenec M, Kazdova L, Landa V, et al. Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat. Hypertension 2008; 51:148-153.
35. Saad Y, Garrett MR, Manickavasagam E, et al. Fine-mapping and comprehensive transcript analysis reveals nonsynonymous variants within a novel 1.17Mbblood pressure QTL region on rat chromosome 10. Genomics 2007; 89:343-353.
36. Lee SJ, Liu J, Westcott AM, et al. Substitution mapping in dahl rats identifies two distinct blood pressure quantitative trait loci within 1.12- and 1.25-mb intervals on chromosome 3. Genetics 2006; 174:2203-2213.
37. Seda O, Liska F, Sedová L, et al. A 14-gene region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and visceral adiposity. Folia Biol (Praha) 2005; 51:53-61.
38. Cowley AW Jr, Roman RJ, Jacob HJ. Application of chromosomal substitution techniques in gene-function discovery. J Physiol 2004; 554 (Pt 1):46-55.
39. Darvasi A. Interval-specific congenic strains (ISCS): an experimental design for mapping a QTL into a 1-centimorgan interval. Mamm Genome 1994; 8:163-167.
40. Jansen RC, Nap JP. Genetical genomics: the added value from segregation. Trends Genet 2001; 17:388-391.
41. Passador-Gurgel G, Hsieh WP, Hunt P, et al. Quantitative trait transcripts for nicotine resistance in Drosophila melanogaster. Nat Genet 2007; 39:264- 268.
42. Hubner N, Wallace CA, Zimdahl H, et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 2005; 37:243-253.
43. Jirout ML, Friese RS, Mahapatra NR, et al. Discovery of genetic regulatory network controlling catecholamine biosynthesis in the spontaneously hypertensive rat [abstract]. In: Rat Genomics & Models; 6-9 December 2007; Cold Spring Harbor.
44. Petretto E, Sarwar R, Grieve I, et al. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet 2008; 40:546-552.
45. Pravenec M, Churchill PC, Churchill MC, et al. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat Genet 2008 (in press).